USPTO 2015–2025 USPTO PatentsView Foreign Corporation

National Center FOR Child Health AND Development

USPTO PatentsView assignee record - 13 granted patents across 14 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, National ranks #21,490 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 14 technology areas.

#21,490
of 49,997 US assignees by volume
Top 29%
by Innovation Score (43.0/100)
12.2
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21490 · Foreign Corporation #21,490 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,490/49,997
  • PHOTO-FINISH MyMD Pharmaceuticals
  • CPC-FOCUS A61P · 14 areas
  • INNOV-PAR 43.0/100
  • CLAIMS-RICH 12.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: MyMD Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How National’s 43.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around National

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows National's Innovation Score is 43.0/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for National?

Each dot is one of National’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). National’s own 12.2 claims/patent is at or below the 12.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 510152025 Granted patents (volume) Avg claims / patent MyMD Pharmaceuticals, Inc. - 13, 13.62Mymd Pharmaceutic…Myriota Pty Ltd - 13, 22.31Myriota PtyNanjing Normal University - 13, 8.77Nanjing Normal Un…Nantes Universite - 13, 13.54Nantes UniversiteNational Institute OF Agrobiological Sciences - 13, 11.15National Institut…Nationz Technologies Inc. - 13, 12.46NationzNavitaire LLC - 13, 12.69NavitaireNdelectric Co., Ltd. - 13, 17.62NdelectricNational Center FOR Child Health AND Development - 13, 12.23National Center F…
National vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where National's grants concentrate

National Center FOR Child Health AND Development is a focused PatentsView assignee: 14 CPC subclasses with 84.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2020. By volume, National sits between MyMD Pharmaceuticals, Inc. and Ndelectric Co., Ltd..

National's three-year grant acceleration

National Center FOR Child Health AND Development shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at National's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows National holds 13 patents at rank #21,483, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near National

By rank, the assignees closest to #21,483 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in National's primary technology class.

National's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201620172018202020212022202320242025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
National Center FOR Child Health AND Development patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 2 15.4%
2017 2 15.4%
2018 2 15.4%
2020 1 7.7%
2021 1 7.7%
2022 1 7.7%
2023 1 7.7%
2024 2 15.4%
2025partial year 1 7.7%

Which technologies does National Center FOR Child Health AND Development patent most?

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

National Center FOR Child Health AND Development's patent record in context - here's where to go next.

  • National Center FOR Child Health AND Development's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 84.6% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #21,490 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare National Center FOR Child Health AND Development against MyMD Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.